Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Emer

Dermatology West Hollywood, CA Medical Doctor

NPI 1912164872 CMS profile 313403

9201 W Sunset Blvd Ste 510, West Hollywood, CA 90069

Open in the dashboard

General payments

$59,645

143 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Emer of West Hollywood, CA is reported in the CMS Open Payments database as having received $59,645 across 143 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,193 14
2024 General $1,127 18
2023 General $2,545 12
2022 General $1,547 16
2021 General $9,797 13
2020 General $4,699 14
2019 General $38,737 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Emer
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Jason Emer were reported at $1,193. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Jason Emer Dermatology median Middle half National median
2019 $38,737 $454 $129–$1,240 $163
2020 $4,699 $235 $81–$756 $114
2021 $9,797 $377 $108–$1,108 $132
2022 $1,547 $514 $143–$1,391 $149
2023 $2,545 $607 $159–$1,674 $160
2024 $1,127 $751 $204–$1,903 $164
2025 $1,193 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Apyx Medical Corporation $31,300 19 payments
  2. Merz North America, Inc. $14,730 32 payments
  3. Solta Medical, a division of Bausch Health US, LLC $10,006 5 payments
  4. AbbVie, Inc. $1,898 27 payments
  5. Galderma Laboratories, L.P. $582 20 payments
  6. Allergan Inc. $478 29 payments
  7. Musculoskeletal Transplant Foundation Inc. $425 7 payments
  8. Revance Therapeutics, Inc. $143 1 payment
  9. Sientra, Inc. $42 1 payment
  10. Endo Pharmaceuticals Inc. $26 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $42,136 11 payments
  2. Food and Beverage $8,851 126 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,001 2 payments
  4. Travel and Lodging $497 3 payments
  5. Entertainment $160 1 payment
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $12,288 26 payments
  2. Xeomin musculoskeletal $1,525 2 payments
  3. BOTOX $180 8 payments
  4. DAXXIFY $143 1 payment
  5. BOTOX COSMETIC $62 6 payments
  6. ASCLERA $43 1 payment
  7. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $42 1 payment
  8. STELARA $15 1 payment
  9. TREMFYA $15 1 payment
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

143 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record